BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Art Pappas will speak about future trends in biotechnology at the Charlotte Biotechnology Conference in Charlotte, NC
News | 10. 27. 2010
